Drug profile · INN
protirelin
THYREL TRH
protirelin (THYREL TRH) is a thyrotropin-releasing hormone receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — protirelin
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
protirelin (THYREL TRH) is a thyrotropin-releasing hormone receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Thyrotropin-releasing hormone receptor agonist
Primary target: Thyrotropin-releasing hormone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is protirelin?
protirelin (THYREL TRH) is a thyrotropin-releasing hormone receptor agonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for protirelin?
THYREL TRH is a marketed brand name for protirelin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of protirelin?
protirelin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.